Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary cholangitis.

Residents at AIIMS Mangalagiri's hostel first reported intense vomiting and diarrhea three days prior, sparking an immediate ...

This year, National Poison Prevention Week is March 20th–26th. The Pet Poison Helpline receives thousands of calls annually ...

Over 75 people fell ill after consuming buckwheat flour during Navratri in Baghpat, Bijnor, and Bulandshahr, prompting health investigations and hospitalizations.

This time of year is prime season for these fast-spreading illnesses.

The therapy shows efficacy in improving diarrhea, abdominal pain in GLP-1, GLP-1/GIP-treated patients with diabetes and/or obesity in a small study.

On cold spring mornings in the Nebraska Sandhills, calving season can test even the most experienced ranchers. Twenty-five ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Confirmed objective responses were observed at 8.6 and 10 mg/kg q3w, with a high overall disease control rate in late-line metastatic colorectal cancer. Progression-free survival estimates near 7 ...

The FDA has approved the first medication for cholestatic pruritus in adult patients with primary biliary cholangitis.The approval of linerixibat (Lynavoy, GSK) — an ileal bile acid transporter ...

Linerixibat targets pruritus pathobiology in PBC by blocking ileal bile acid reuptake, aiming to lower circulating pruritogenic bile acid–related mediators. GLISTEN demonstrated greater 24-week WI-NRS ...

The late-stage results handily beat earlier trials of the company’s diabetes blockbuster Mounjaro, which racked up sales of $23 billion in 2025.